Dustin S. Sjuts

Insider Reports History

Location
Newark, CA
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dustin S. Sjuts:

Company Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. President Common Stock 167,550 $844,871 $5.04 18 Mar 2024 Direct

Insider Reports Filed by Dustin S. Sjuts

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000147929024000068-sjuts-dustin-s-2024-03-15 Revance Therapeutics, Inc. 15 Mar 2024 2 -$62,186 4 President 19 Mar 2024, 18:45
/report/000147929024000054-sjuts-dustin-s-2024-02-29 Revance Therapeutics, Inc. 29 Feb 2024 1 $0 4 President 04 Mar 2024, 17:34
/report/000147929024000006-sjuts-dustin-s-2023-12-31 Revance Therapeutics, Inc. 31 Dec 2023 1 +$1,972 4 President 03 Jan 2024, 16:50
/report/000147929023000116-sjuts-dustin-s-2023-12-15 Revance Therapeutics, Inc. 15 Dec 2023 1 -$38,073 4 President 18 Dec 2023, 16:32
/report/000147929023000097-sjuts-dustin-s-2023-08-11 Revance Therapeutics, Inc. 11 Aug 2023 2 -$168,318 4 President 15 Aug 2023, 16:15
/report/000147929023000082-sjuts-dustin-s-2023-06-30 Revance Therapeutics, Inc. 30 Jun 2023 1 +$15,606 4 President 05 Jul 2023, 21:11
/report/000147929023000079-sjuts-dustin-s-2023-06-09 Revance Therapeutics, Inc. 09 Jun 2023 1 -$154,096 4 President 13 Jun 2023, 20:09
/report/000147929023000039-sjuts-dustin-s-2023-03-15 Revance Therapeutics, Inc. 15 Mar 2023 1 -$90,939 4 President 17 Mar 2023, 15:21
/report/000147929023000019-sjuts-dustin-s-2023-02-15 Revance Therapeutics, Inc. 15 Feb 2023 1 -$91,859 4 President 16 Feb 2023, 19:29
/report/000147929023000013-sjuts-dustin-s-2023-01-31 Revance Therapeutics, Inc. 31 Jan 2023 1 $0 4 President 02 Feb 2023, 20:37
/report/000147929023000002-sjuts-dustin-s-2022-12-31 Revance Therapeutics, Inc. 31 Dec 2022 1 +$7,369 4 President 03 Jan 2023, 15:28
/report/000147929022000105-sjuts-dustin-s-2022-12-15 Revance Therapeutics, Inc. 15 Dec 2022 1 -$62,694 4 President 16 Dec 2022, 15:11
/report/000147929023000035-sjuts-dustin-s-2022-09-22 Revance Therapeutics, Inc. 22 Sep 2022 2 -$679,358 4 President 09 Mar 2023, 20:45
/report/000147929022000073-sjuts-dustin-s-2022-06-30 Revance Therapeutics, Inc. 30 Jun 2022 1 +$11,747 4 President 05 Jul 2022, 18:15
/report/000120919122019707-sjuts-dustin-s-2022-03-15 Revance Therapeutics, Inc. 15 Mar 2022 1 -$28,975 4 President 17 Mar 2022, 17:43
/report/000147929022000025-sjuts-dustin-s-2022-02-15 Revance Therapeutics, Inc. 15 Feb 2022 2 -$32,427 4 President 17 Feb 2022, 19:54
/report/000147929023000073-sjuts-dustin-s-2022-02-02 Revance Therapeutics, Inc. 02 Feb 2022 2 -$726,003 4 President 16 May 2023, 20:29
/report/000147929022000017-sjuts-dustin-s-2022-02-02 Revance Therapeutics, Inc. 02 Feb 2022 1 $0 4 President 04 Feb 2022, 19:38
/report/000147929021000175-sjuts-dustin-s-2021-12-15 Revance Therapeutics, Inc. 15 Dec 2021 1 -$8,167 4 President 17 Dec 2021, 16:29
/report/000147929021000167-sjuts-dustin-s-2021-11-09 Revance Therapeutics, Inc. 09 Nov 2021 1 $0 4 President 10 Nov 2021, 19:32
/report/000147929021000134-sjuts-dustin-s-2021-06-30 Revance Therapeutics, Inc. 30 Jun 2021 1 +$21,246 4 Chief Commercial Officer 02 Jul 2021, 19:56